Vomaris Announces First Patient Enrollment in Study on Effects of Bioelectric Wound Care in Hidradenitis Suppurativa

TEMPE, Ariz., Oct. 18, 2021 /PRNewswire/ — Vomaris Innovations, Inc. announces the first patient enrollment in a study using its bioelectric antimicrobial wound care technology following surgical treatment for Hidradenitis Suppurativa (HS).

About HS
HS is a chronic inflammatory skin condition that affects 1-4% of the global population. It occurs more often in women than men and is characterized by recurring pus-filled skin abscesses that drain and can develop tunnels under the skin. This results in pain, scarring and suffering that is both physical and emotional. Because HS most commonly occurs in areas where skin rubs together, such as the armpits, groin, buttocks and breasts, it presents unique treatment challenges.

Current treatments are aimed at managing lesions and their symptoms, trying to reduce recurrence and scarring, and coping with the associated psychological impact. Unfortunately, no one treatment is universally effective and there is no cure for HS. When tunnels develop under the skin, a surgical procedure called deroofing is commonly done. While this removes painful lesions and preserves the surrounding tissue, it leaves large open wounds … read more

Newsletter Signup

Subscribe to our weekly newsletter below for an update of everything from the week